Biopsy News and Research

RSS

Biopsy is the removal of cells or tissues for examination by a pathologist. The pathologist may study the tissue under a microscope or perform other tests on the cells or tissue. There are many different types of biopsy procedures. The most common types include: (1) incisional biopsy, in which only a sample of tissue is removed; (2) excisional biopsy, in which an entire lump or suspicious area is removed; and (3) needle biopsy, in which a sample of tissue or fluid is removed with a needle. When a wide needle is used, the procedure is called a core biopsy. When a thin needle is used, the procedure is called a fine-needle aspiration biopsy.

Irreversible infertility risk in men linked to urogenital infections

In couples who have not been able to have children, male infertility is the cause in at least half of cases. In 6-10% the cause is a urogenital infection.

14 Jun 2017

Developing synthetic mediums for growing organoids

Organoids are bits of tissue grown in vitro, in a near-physiological 3D setting. The particularity consists in the fact that organoids retain features of the patient they are derived from, even when cultured outside of the human body. This is very different from what traditional, conventional cell culture has been able to do over the past 50 years or so.

13 Jun 2017

Roche to showcase new solutions for lab innovation at EuroMedLab

Roche announced today that it will be showcasing new solutions for lab innovation and leadership at the 22nd IFCC–EFLM European Congress of Clinical Chemistry and Laboratory Medicines in Athens, Greece, 11–15 June.

From Roche Sequencing and Life Science 13 Jun 2017

Emerging blood test could offer effective alternative to detect cancer

Research into a blood test that may spot cancers sooner and allow more targeted treatment is to be presented by a University of Leicester researcher.

12 Jun 2017

New diagnostic test uses machine learning to accurately detect aggressive prostate cancer

A new diagnostic developed by Alberta scientists will allow men to bypass painful biopsies to test for aggressive prostate cancer.

9 Jun 2017

New genomic sequencing approach could be first step toward blood tests for early cancer detection

In a study of 124 patients with advanced breast, lung, and prostate cancers, a new, high-intensity genomic sequencing approach detected circulating tumor DNA at a high rate.

5 Jun 2017

Genetic sequencing could help direct treatment for 72% of advanced cancer patients

A new analysis finds that nearly three-quarters of 500 patients with advanced cancer could be referred to a potential targeted treatment based on the results of a comprehensive analysis of their tumor's genetic landscape.

2 Jun 2017

Yale researchers find racial and ethnic disparities in use of genetic test for breast cancer

A genetic test that helps doctors determine how best to treat breast cancer - and whether chemotherapy is likely to help- is significantly more likely to be administered to white women than blacks or Hispanics, a Yale study has found.

1 Jun 2017

Patients who undergo Fontan surgery for congenital heart defect have liver fibrosis risk, study reveals

Patients who undergo the Fontan operation as children for a complex congenital heart defect are at risk of developing progressive liver fibrosis, a buildup of fibrous deposits, as a result of the circulation created by the surgery, according to a new study.

31 May 2017

Moffitt researchers hope to improve personalized radiation therapy for head and neck cancer patients

Radiation therapy is one of the most common treatments used to fight cancer, with an estimated 500,000 people each year receiving radiation therapy either alone or in combination with other treatments.

31 May 2017

New handheld tissue scanner allows looking under the skin of psoriasis patients

A newly developed tissue scanner allows looking under the skin of psoriasis patients. This provides clinically relevant information, such as the structure of skin layers and blood vessels, without the need for contrast agents or radiation exposure.

31 May 2017

Prolaris becomes first genetic test to receive Medicare coverage for favorable intermediate and low-risk prostate cancer

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that Palmetto GBA, a Medicare Administrative Contractor that assesses molecular diagnostic technologies, has issued a positive final Local Coverage Determination to expand Medicare coverage of the Prolaris test.

29 May 2017

Researchers use chemical array to find malignant cells within melanoma tumor

Melanoma is a particularly difficult cancer to treat once it has metastasized, spreading throughout the body. University of Illinois researchers are using chemistry to find the deadly, elusive malignant cells within a melanoma tumor that hold the potential to spread.

26 May 2017

Newly developed ultrafast cardiac imaging test changes clinical management in one-third of patients

Researchers in the UK and Peru have developed a faster and cheaper cardiac imaging test that can be used in developing countries, according to the results of the INCA-Peru study presented today at EuroCMR 2017.

26 May 2017

Multi-protein biomarker blood test to detect breast cancer can potentially reduce use of biopsy

A new study published in Clinical Breast Cancer demonstrates that Videssa® Breast, a multi-protein biomarker blood test to detect breast cancer, can help inform better decision-making after abnormal mammogram or other breast imaging results and potentially reduce use of biopsy by up to 67 percent.

24 May 2017

Tumor mutation load in patient's biopsy varies by age and type of cancer

A team of investigators led by researchers at Georgetown Lombardi Comprehensive Cancer Center has found that the tumor mutation load, or TML, in a patient's cancer biopsy varied by age and the type of cancer, along with several other factors.

18 May 2017

Study finds early diagnostic MRI to be cost-effective method for detecting prostate cancer

A diagnostic MRI followed by one of three MRI-guided biopsy strategies is a cost-effective method to detect prostate cancer, according to a new study out of Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center.

17 May 2017

NIBIB-funded scientists develop rapid and accurate tool for detecting early pancreatic cancer

Researchers funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) have developed a new tool for detecting early pancreatic cancer.

17 May 2017

New IsoPSA assay detects prostate cancer more precisely than current tests

A team of researchers from Cleveland Clinic, Louis Stokes Cleveland VA Medical Center, Kaiser Permanente Northwest, and other clinical sites have demonstrated that a new blood test known as IsoPSA detects prostate cancer more precisely than current tests in two crucial measures - distinguishing cancer from benign conditions, and identifying patients with high-risk disease.

15 May 2017

Guardant Health introduces new initiative to sequence tumor DNA of one million cancer patients

Guardant Health, the world leader in comprehensive liquid biopsies, announced an ambitious goal to sequence the tumor DNA of more than 1 million cancer patients within five years.

15 May 2017

Biopsy News and Research

Further Reading

Irreversible infertility risk in men linked to urogenital infections

Developing synthetic mediums for growing organoids

Roche to showcase new solutions for lab innovation at EuroMedLab

Emerging blood test could offer effective alternative to detect cancer

New diagnostic test uses machine learning to accurately detect aggressive prostate cancer

New genomic sequencing approach could be first step toward blood tests for early cancer detection

Genetic sequencing could help direct treatment for 72% of advanced cancer patients

Yale researchers find racial and ethnic disparities in use of genetic test for breast cancer

Patients who undergo Fontan surgery for congenital heart defect have liver fibrosis risk, study reveals

Moffitt researchers hope to improve personalized radiation therapy for head and neck cancer patients

New handheld tissue scanner allows looking under the skin of psoriasis patients

Prolaris becomes first genetic test to receive Medicare coverage for favorable intermediate and low-risk prostate cancer

Researchers use chemical array to find malignant cells within melanoma tumor

Newly developed ultrafast cardiac imaging test changes clinical management in one-third of patients

Multi-protein biomarker blood test to detect breast cancer can potentially reduce use of biopsy

Tumor mutation load in patient's biopsy varies by age and type of cancer

Study finds early diagnostic MRI to be cost-effective method for detecting prostate cancer

NIBIB-funded scientists develop rapid and accurate tool for detecting early pancreatic cancer

New IsoPSA assay detects prostate cancer more precisely than current tests

Guardant Health introduces new initiative to sequence tumor DNA of one million cancer patients

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News